KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Total Liabilities: 2011-2025

Historic Total Liabilities for Dynavax Technologies (DVAX) over the last 13 years, with Sep 2025 value amounting to $412.4 million.

  • Dynavax Technologies' Total Liabilities rose 8.36% to $412.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.4 million, marking a year-over-year increase of 8.36%. This contributed to the annual value of $389.5 million for FY2024, which is 3.85% up from last year.
  • As of Q3 2025, Dynavax Technologies' Total Liabilities stood at $412.4 million, which was down 2.81% from $424.3 million recorded in Q2 2025.
  • Dynavax Technologies' Total Liabilities' 5-year high stood at $852.1 million during Q3 2021, with a 5-year trough of $359.2 million in Q2 2023.
  • For the 3-year period, Dynavax Technologies' Total Liabilities averaged around $388.3 million, with its median value being $380.6 million (2024).
  • Per our database at Business Quant, Dynavax Technologies' Total Liabilities surged by 199.93% in 2021 and then slumped by 50.44% in 2022.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Total Liabilities stood at $816.9 million in 2021, then crashed by 50.44% to $404.8 million in 2022, then fell by 7.36% to $375.0 million in 2023, then climbed by 3.85% to $389.5 million in 2024, then climbed by 8.36% to $412.4 million in 2025.
  • Its last three reported values are $412.4 million in Q3 2025, $424.3 million for Q2 2025, and $415.0 million during Q1 2025.